Skip to main content
John Dickinson, MD, Pulmonology, Omaha, NE

John David Dickinson MD

Critical Care Medicine, Pleural Disease


Assistant Professor, Internal Medicine, U of NE Coll of Med

Join to View Full Profile
  • 988102 Nebraska Medical CtrOmaha, NE 68198

  • Phone+1 402-559-4015

  • Fax+1 402-559-8715

Are you Dr. Dickinson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. John Dickinson, MD is a pulmonologist in Omaha, Nebraska. He is currently licensed to practice medicine in Nebraska and Missouri. He is an Assistant Professor at U of NE Coll of Med.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2007 - 2010
  • University of Nebraska College of Medicine
    University of Nebraska College of MedicineClass of 2007
  • Dalhousie University Faculty of Medicine
    Dalhousie University Faculty of MedicineClass of 1989

Certifications & Licensure

  • NE State Medical License
    NE State Medical License 2014 - 2026
  • MO State Medical License
    MO State Medical License 2007 - 2010
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Press Mentions

  • New Cystic Fibrosis Drug Is Major Breakthrough for Patients
    New Cystic Fibrosis Drug Is Major Breakthrough for PatientsJanuary 4th, 2020
  • An Approved Cystic Fibrosis Drug and Point of View from Nebraska in the Heartland of America
    An Approved Cystic Fibrosis Drug and Point of View from Nebraska in the Heartland of AmericaJanuary 1st, 2020